Post-marketing safety evaluation of paroxetine: a real-world pharmacovigilance analysis based on the FDA adverse event reporting system
ObjectiveParoxetine, a selective serotonin reuptake inhibitor widely used in the management of major depressive disorders and other psychiatric disorders, remains insufficiently characterized regarding its adverse event spectrum. Thus, this study wanted to conduct a comprehensive evaluation of its p...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2026-04-01
|
| Edice: | Frontiers in Pharmacology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1744180/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|